Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones

Go back to Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
(NYSE: RCUS) Delayed: 28.19 -0.23 (0.81%)
Previous Close $28.42    52 Week High
Open $28.67    52 Week Low
Day High $29.63    P/E N/A 
Day Low $28.00    EPS
Volume 409,225